CHICAGO – Women with breast cancer and bone metastasis can safely scale back the frequency of their zoledronic acid infusions from every 12 weeks to every 4 weeks without a loss in efficacy,...
CHICAGO – Adding the gonadotropin-releasing hormone agonist goserelin (Zoladex) to adjuvant or neoadjuvant chemotherapy boosted fertility prospects in premenopausal women with early-stage...
CHICAGO – A full 13% of patients diagnosed with hepatocellular carcinoma did not have underlying cirrhosis in a national sample of 1,500 veterans.
Although hepatocellular carcinoma (HCC) in patients...
Fear seems to be a major driver of contralateral prophylactic mastectomy after initial breast cancer surgery.
Almost two-thirds of those who had the procedure had no clinical indication for it,...
In patients with colorectal cancer, laparoscopic resection reduced total hospital stay by a median of 2 days, compared with open surgery, researchers reported online May 5 in the Journal of Clinical...
WAIKOLOA, HAWAII – The spectacular developments in the treatment of advanced melanoma that began with approval of ipilimumab in 2011 continue to accelerate, and these advances promise to keep...
ORLANDO – Tumors detected following prostate-specific antigen screening in black men aged 40-54 years had more favorable clinico-pathologic characteristics than those detected in black men aged 55-70...
If current trends hold true, pancreatic and liver cancer will overtake breast and colorectal cancer to become the second- and third-most-common causes of cancer-related deaths in the United States by...
ORLANDO – A single prostate specific antigen level measurement before age 60 years in the setting of opportunistic screening predicted lethal prostate cancer in later life, according to findings from...
ALEXANDRIA, VA. - Annual low-dose CT screening of patients at high risk for lung cancer is likely to significantly increase detection of early cancers, but that screening will come at a price,...
